Evidence-Based Follow-Up Schedules After Primary Cancer Treatment Rachael L. MortonJohn F. Thompson Melanoma 29 June 2020 Pages: 4067 - 4069
Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody Kevin P. LabadieJonathan G. Sham Hepatobiliary Tumors 04 June 2020 Pages: 4070 - 4072
Diaphragmatic Involvement Should Not Preclude Curative-Intent Surgical Resection for Hepatocellular Carcinoma Aslam EjazTimothy M. Pawlik Hepatobiliary Tumors 23 June 2020 Pages: 4073 - 4074
Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases Jeremy D. KratzNoelle K. LoConte Hepatobiliary Tumors 22 May 2020 Pages: 4075 - 4078
Gastric Remnant Cancer: Is it different From Primary Gastric Cancer? Insights Into a Unique Clinical Entity Mashaal Dhir Gastrointestinal Oncology 10 June 2020 Pages: 4079 - 4081
Radiomics for Diagnosing Lateral Pelvic Lymph Nodes in Rectal Cancer: Artificial Intelligence Enabling Precision Medicine? Tarik SammourSergei Bedrikovetski Colorectal Cancer 06 August 2020 Pages: 4082 - 4083
Editorial Comment on: DPP9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer Takehiko Yokobori Colorectal Cancer 22 June 2020 Pages: 4084 - 4085
Electrochemotherapy for Pancreatic Cancer: An Emerging Treatment Modality? Jin He Pancreatic Tumors 04 July 2020 Pages: 4086 - 4087
The Musician, Instrument, or Orchestra? Todd L. Demmy Thoracic Oncology 08 July 2020 Pages: 4088 - 4090
A Potential Indication for Adjuvant Therapy in Node-Negative Esophageal Squamous Cell Carcinoma Andrew M. Popoff Thoracic Oncology 20 July 2020 Pages: 4091 - 4092
Variation in Adequate Lymph Node Yield for Gastric, Lung, and Bladder Cancer: Attributable to the Surgeon, Pathologist, or Hospital? Christopher T. AquinaMatthew TruongAdan Z. Becerra Health Services Research and Global Oncology 06 May 2020 Pages: 4093 - 4106
ASO Author Reflections: Variation in Adequate Lymph Node Yield: Current Status and Where Do We Go from Here? Christopher T. AquinaAdan Z. Becerra ASO Author Reflections 04 May 2020 Pages: 4107 - 4108
The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years Marc D. MoncrieffBeverly UnderwoodHarald J. Hoekstra Melanoma Open access 04 July 2020 Pages: 4109 - 4119
ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years Marc MoncrieffBeverly UnderwoodHarald Hoekstra ASO Author Reflections Open access 10 July 2020 Pages: 4120 - 4121
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma Lauren S. LevineKelly M. MahuronAdil I. Daud Melanoma 02 June 2020 Pages: 4122 - 4130
ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma Kelly M. MahuronLauren S. LevineAdil I. Daud ASO Author Reflections 02 June 2020 Pages: 4131 - 4132
Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients Isabela Bartelli FonsecaMarcus Vitor Nunes LindoteJoão Pedreira Duprat Neto Melanoma 07 August 2020 Pages: 4133 - 4140
ASO Author Reflections: Sentinel Node Biopsy—Retirement Will Have to Wait Eduardo BertolliVinicius Fernando Calsavara ASO Author Reflections 31 July 2020 Pages: 4141 - 4142
Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial Fumitoshi HirokawaKoji KomedaKazuhisa Uchiyama Hepatobiliary Tumors 04 June 2020 Pages: 4143 - 4152
Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis Tatsuya OrimoToshiya KamiyamaAkinobu Taketomi Hepatobiliary Tumors 25 June 2020 Pages: 4153 - 4163
ASO Author Reflections: Is Hepatectomy Plus Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement Justified? Tatsuya OrimoToshiya KamiyamaAkinobu Taketomi ASO Author Reflections 23 June 2020 Pages: 4164 - 4165
Robotic Resection of Hilar Cholangiocarcinoma Marcel Autran MachadoBruno V. MattosFabio Makdissi Hepatobiliary Tumors 03 May 2020 Pages: 4166 - 4170
Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas Yoshitsugu NakanishiKeisuke OkamuraSatoshi Hirano Hepatobiliary Tumors 03 May 2020 Pages: 4171 - 4180
Laparoscopic Caudate Lobectomy for Cholangiocarcinoma of Caudate Lobe Invading Middle Hepatic Vein Hai-Feng WanKun-Lin XieJi-Wei Huang Hepatobiliary Tumors 16 May 2020 Pages: 4181 - 4185
ASO Author Reflections: Laparoscopic Caudate Lobectomy: A Feasible and Safe Approach for Cholangiocarcinoma of the Caudate Lobe Invading the Middle Hepatic Vein Guo-Teng QiuKun-Lin XieJi-Wei Huang ASO Author Reflections 18 May 2020 Pages: 4186 - 4187
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial) Yoshihiro MiseKiyoshi HasegawaNorihiro Kokudo Gastrointestinal Oncology 08 June 2020 Pages: 4188 - 4195
Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis Christian GalataUlrich RonellenfitschJulia Hardt Gastrointestinal Oncology Open access 02 June 2020 Pages: 4196 - 4203
Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered? A. TavaresX. WenM. Dinis-Ribeiro Gastrointestinal Oncology 04 May 2020 Pages: 4204 - 4215
Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer Eui Soo HanHo Seok SeoHan Hong Lee Gastrointestinal Oncology 05 May 2020 Pages: 4216 - 4224
Impact of Extracapsular Extension of Lymph Node in Adenocarcinoma of the Stomach Bofei LiIan Yu-Hong WongSimon Law Gastrointestinal Oncology 05 May 2020 Pages: 4225 - 4232
ASO Author Reflections: Extracapsular Extension of Lymph Node: An Important Consideration for Gastric Cancer Bofei LiAnthony W. I. LoSimon Law ASO Author Reflections 07 May 2020 Pages: 4233 - 4234
Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer Kazuki KanoTakanobu YamadaTakashi Oshima Gastrointestinal Oncology 18 May 2020 Pages: 4235 - 4247
ASO Author Reflections: Association Between the Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer Kazuki KanoTakanobu YamadaTakashi Oshima ASO Author Reflections 27 May 2020 Pages: 4248 - 4249
Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer Guo-Ming ChenShu-Qiang YuanYing-Bo Chen Gastrointestinal Oncology 06 June 2020 Pages: 4250 - 4260
ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery Guo-Ming ChenRun-Cong NieYing-Bo Chen ASO Author Reflections 13 May 2020 Pages: 4261 - 4262
The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis Yoshikuni KawaguchiJean-Nicolas Vauthey Colorectal Cancer 14 August 2020 Pages: 4263 - 4270
ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis Yoshikuni KawaguchiJean-Nicolas Vauthey ASO Author Reflections 08 July 2020 Pages: 4271 - 4272
Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer Ryota NakanishiTakashi AkiyoshiHiroya Kuroyanagi Colorectal Cancer 07 August 2020 Pages: 4273 - 4283
ASO Author Reflections: CT-Based Radiomics Model to Predict Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer Ryota NakanishiTakashi Akiyoshi ASO Author Reflections 01 August 2020 Pages: 4284 - 4285
Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group Alexandre DoussotDewi VernereyFrench Research Group of Rectal Cancer Surgery (GRECCAR) Colorectal Cancer 04 June 2020 Pages: 4286 - 4293
ASO Author Reflections: Challenges in the Management of Synchronous Prostate Cancer and Rectal Cancer: Towards Double Organ Preservation? Alexandre DoussotZaher Lakkis ASO Author Reflections 29 May 2020 Pages: 4294 - 4295
Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study Lizhi ShaoZhenyu LiuJie Tian Colorectal Cancer Open access 29 July 2020 Pages: 4296 - 4306
ASO Author Reflections: Radiopathomics Strategy of Combing Multi-scale Tumor Information on Pretreatment to Predict the Pathologic Response to Neoadjuvant Therapy Jie TianXinjuan FanGuanyu Yang ASO Author Reflections Open access 03 June 2020 Pages: 4307 - 4308
Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer Wen-Shih HuangFeng-Che KuanWen-Cheng Chen Colorectal Cancer 13 August 2020 Pages: 4309 - 4318
Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis S. HoendervangersJ. P. M. BurbachH. M. Verkooijen Colorectal Cancer Open access 10 June 2020 Pages: 4319 - 4336
Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer Kazuhiro SasoNorikatsu MiyoshiHidetoshi Eguchi Translational Research and Biomarkers 30 July 2020 Pages: 4337 - 4347
Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma Neal BhutianiYan LiRobert C. G. Martin II Translational Research 17 July 2020 Pages: 4348 - 4359
High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer Seded BaatarTuya BaiHiroshi Saeki Translational Research and Biomarkers 30 April 2020 Pages: 4360 - 4368
ASO Author Reflections: High RAD18 Expression is Associated with Disease Progression and Poor Prognosis for Patients with Gastric Cancer Takehiko YokoboriNavchaa GombodorjHiroshi Saeki ASO Author Reflections 08 May 2020 Pages: 4369 - 4370
Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma Yuan-ning GuoDong-ping TianMin Su Thoracic Oncology 09 June 2020 Pages: 4371 - 4381
